What Is Female Infertility?
Female infertility is recognized as a disease of the reproductive system by the World Health Organization (WHO). It is defined as the failure to achieve pregnancy after 12 months or more of regular, unprotected sexual intercourse.
It’s not a personal shortcoming or misfortune—it’s a medical condition with identifiable causes and effective treatments.
When to seek help
Age | When to See a Specialist |
Under 35 years | After 12 months of trying |
35–39 years | After 6 months of trying |
40+ years | Immediately |
Source: ACOG. Female age-related fertility decline. Committee Opinion No. 589. 2014.
Why the difference?
Female fertility declines gradually after 30, more sharply after 35, and significantly after 40. By age 40, the average probability of conception per cycle is often reported to be less than 5%.
Types of Infertility
Not all infertility is the same. Understanding which type you’re experiencing helps guide the proper diagnostic approach:
Based on history:
Primary infertility – You’ve never achieved a pregnancy after 12 months of regular, unprotected intercourse (or 6 months if you are older than 35 years).
Secondary infertility – You’ve had a previous pregnancy (even if it ended in miscarriage), but cannot conceive again. This represents the most commonly observed form of infertility globally.
Based on cause:
Unexplained infertility – All tests come back normal, yet pregnancy doesn’t occur. This accounts for 15–30% of cases.
What Are the Causes of Female Infertility?
Female infertility can arise from issues affecting any part of the reproductive system. The encouraging news: most causes can be identified and treated.
Cause Category | Percentage of Cases |
Ovulatory disorders | 25–40% |
Tubal factors | 20–35% |
Uterine factors | 10–15% |
Endometriosis | 10–15% |
Unexplained infertility | 15–30% |
Ovulatory Disorders (25–40% of Female Infertility)
Ovulation—the monthly release of an oocyte (egg)—is essential for conception. When it doesn’t happen regularly, pregnancy becomes difficult. These disorders are among the most treatable causes of infertility.
PCOS (Polycystic Ovary Syndrome) – The most common cause of ovulatory infertility, responsible for approximately 70% of anovulatory cases. Characterized by a combination of irregular ovulation, elevated androgens, and/or polycystic ovarian morphology, with diagnosis requiring at least two of these features.
Primary Ovarian Insufficiency (POI) – Also called premature ovarian failure, this occurs when the ovaries stop functioning before age 40. The ovaries no longer produce eggs or adequate estrogen, although intermittent ovulation can sometimes occur when eggs are released irregularly. It may be caused by autoimmune conditions, genetics, or chemotherapy.
Hypothalamic Amenorrhea – Excessive physical or emotional stress, very high or very low body weight, can disrupt the production of hormones (FSH and LH) that stimulate ovulation.
Hyperprolactinemia – Elevated prolactin levels from the pituitary gland suppress estrogen production and can cause infertility. Usually caused by pituitary issues and is highly treatable with medication.
Thyroid Disorders – Both hyperthyroidism and hypothyroidism can interfere with ovulation. Research suggests thyroid dysfunction may reduce ovulation rates.
→ Treatment option: Ovulation Induction
What Are the Structural Causes?
Physical abnormalities in the reproductive tract can prevent the egg and sperm from meeting or interfere with the implantation of a fertilized embryo.
Tubal Factors (20–35% of Female Infertility)
Pelvic Inflammatory Disease (PID) – Infection of the reproductive organs, often caused by STIs such as chlamydia or gonorrhea. PID can lead to scarring that may block the fallopian tubes.
Previous pelvic surgery – Surgery in the pelvic area, including for ectopic pregnancy, can cause scar tissue (adhesions) that may affect tubal function.
Hydrosalpinx – When the fallopian tubes are blocked and filled with fluid. Research indicates that inflammatory cytokines in this fluid may reduce the likelihood of implantation success by approximately 50%.
Uterine Factors (10–15% of Female Infertility)
Uterine Fibroids – Benign growths in or around the uterine wall. Submucosal fibroids most significantly affect fertility by interfering with implantation.
Uterine Polyps – Small growths of endometrial tissue that may interfere with embryo implantation.
Asherman Syndrome – Uterine scar tissue formed after surgery. Pregnancy chances correlate with severity: approximately 54% for mild, 27% for moderate, and 10% for severe cases. Success depends on restoring the uterine cavity and healthy menstrual flow.
Congenital Uterine Anomalies – Structural abnormalities present from birth, such as a septate or bicornuate uterus, may affect implantation and can increase miscarriage risk.
→ Diagnostic procedure: HSG (Hysterosalpingography)
How Does Endometriosis Affect Fertility?
Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus—on the ovaries, fallopian tubes, or other pelvic structures. It affects approximately 10–20% of women of reproductive age.
Endometriosis may affect fertility through multiple mechanisms:
Pelvic adhesions that distort anatomy and may block the fallopian tubes.
Chronic inflammation can damage oocytes and impair implantation.
Endometriomas (ovarian cysts) may lower AMH levels, reflecting reduced ovarian reserve.
Research indicates that 30–50% of women with endometriosis may experience infertility, particularly in moderate to severe cases, while the remainder appear to maintain fertility.
→ Learn more: Endometriosis
How Does Age Affect Female Fertility?
Age is one of the most significant factors influencing female fertility. Unlike men, women are born with all the eggs they will ever have—and both the quantity and quality of these eggs decline over time.
Age | Monthly Conception Rate | Key Considerations |
Under 25 years | 25–30% | Peak fertility; lowest risk of complications |
26–30 years | 20–25% | Still high fertility; gradual decline begins after 30 |
31–35 years | 15–20% | Moderate decline; seek help after 12 months of trying |
36–38 years | 10–15% | Accelerated decline at 37; around 25,000 eggs remain; seek help after 6 months |
39–42 years | 5–10% | Significant decrease; aneuploidy rises to approximately 40–50%; miscarriage risk approximately 30–40% |
Over 42 years | <5% | Immediate evaluation recommended; aneuploidy approximately 60%; miscarriage risk approximately 50% |
Source: ACOG Committee Opinion No. 589 (2014); StatPearls Female Infertility (2025)
The biological reasons for age-related fertility decline include:
Decreasing egg quantity – By age 37–38, approximately 25,000 eggs remain.
Declining egg quality – Aneuploidy (abnormal chromosome number) rates rise from approximately 20% at age 30 to approximately 60% at age 40.
Increased miscarriage risk – Rises from approximately 10% at ages 20–24 to 50% at ages 40–44.
What Risk Factors Affect Female Fertility?
Beyond specific medical conditions, several lifestyle and environmental factors can impair fertility. The encouraging news is that many of these are changeable.
Risk Factor | Effect on Female Fertility |
Smoking | Reduces fertility by approximately 30%, may damage eggs and fallopian tubes; associated with accelerated menopause |
Weight | BMI <18 or >30 may negatively affect fertility; obesity can disrupt ovulation |
Alcohol | Heavy consumption has been associated with increased infertility risk |
STIs | Untreated chlamydia/gonorrhea can cause tubal damage |
Environmental Toxins | Research suggests air pollution may increase infertility risk by approximately 10%; phthalates (chemicals used to make plastic soft) may affect egg quality |
Source: Homan GF, et al. Lifestyle factors and reproductive performance. Hum Reprod Update. 2007;13(3).
Key insight:
Smoking contributes to an estimated 13–15% of all infertility cases. Quitting smoking prior to treatment is associated with improved natural and assisted reproduction outcomes.
How Is Female Infertility Diagnosed?
A thorough fertility evaluation helps identify the underlying cause and guides treatment decisions. Testing is generally straightforward and less invasive than many people fear. Both partners should be evaluated, as approximately 40% of infertility cases involve a male factor.
What Are the Female Diagnostic Tests?
Test | What It Checks |
Hormonal Panel | FSH, LH, AMH (ovarian reserve), estradiol, prolactin, thyroid (TSH). Simple blood test. |
Transvaginal Ultrasound | Ovaries (follicle count, cysts), uterus (fibroids, polyps). Non-invasive. |
HSG | Tubal patency—are the fallopian tubes open? X-ray with contrast dye. Provides indirect information about the uterine cavity shape. |
Laparoscopy | Direct visualization of pelvic organs. It is the gold standard for diagnosing endometriosis when clinically indicated. |
Source: Practice Committee of ASRM. Diagnostic evaluation of the infertile female. Fertil Steril. 2015;103(6).
Additional tests:
Hysteroscopy (camera inserted into the uterus) and Sonohysterography (saline-infused ultrasound for evaluating polyps and uterine abnormalities).
What Are the Treatment Options?
Treatment follows a stepwise approach, starting with simpler options and progressing based on diagnosis, age, and response.
Lifestyle Modifications: The First Step
Weight reduction (achieving a BMI of 19–25) restores ovulation in 50–60% of overweight women with PCOS. Quitting smoking prior to treatment is associated with improved natural and assisted reproduction outcomes.
What Medications Are Available?
Ovulation Induction – Medications to stimulate egg development and release:
Clomiphene citrate – First-line oral medication. Induces ovulation in approximately 80% of women with cumulative pregnancy rates of approximately 40% over six cycles.
Letrozole – Increasingly preferred for PCOS. Studies show a higher live birth rate with letrozole than with clomiphene (27.5% vs 19.1%).
Gonadotropins – Injectable hormones (FSH, LH) for more intensive stimulation. Used when oral medications fail or during IVF.
What Surgical Options Exist?
Hysteroscopy – Camera-guided removal of fibroids, polyps, and adhesions. Removal of fibroids or polyps has been associated with improved pregnancy outcomes.
Laparoscopy – Minimally invasive surgery for endometriosis and adhesions. May improve pregnancy rates in selected patients, particularly in minimal to mild endometriosis.
Salpingectomy – Removal of hydrosalpinx (blocked fallopian tube filled with fluid, preventing sperm from reaching the egg) before IVF. Studies suggest this may improve success rates.
What Is Assisted Reproductive Technology (ART)?
When simpler treatments don’t work—or aren’t appropriate—ART offers highly effective options.
Method | What It Is | Success Rate | Best For |
IUI | Prepared sperm is placed directly into the uterus at ovulation | 4–17%/cycle (4% alone; up to 17% with ovarian stimulation) | Mild male factor, unexplained infertility |
IVF | Eggs are retrieved, fertilized in a lab by adding a drop of sperm, and embryo(s) are transferred to the uterus | 40–50% (<35y); declines with age | Blocked tubes, endometriosis, age >38 |
ICSI | A single sperm is injected directly into each egg | Similar to IVF; fertilization rate 50–80% | Severe male factor, previous IVF failure |
Source: CDC. 2021 ART Fertility Clinic and National Summary Report. 2023; ASRM Practice Committee Guidelines.
IVF Success by Age
Age | Live Birth Rate per Cycle |
Under 35 | 40–50% |
35–37 | 35–40% |
38–40 | 25–30% |
41–42 | 10–15% |
Over 42 | 3–7% |
Source: CDC. 2021 ART Fertility Clinic and National Summary Report. 2023.
*Rates shown are approximate live birth rates per cycle using own eggs and vary by clinic
→ Learn more: Assisted Reproductive Technology
How Can You Protect Your Future Fertility?
Whether you’re not ready for children yet, facing medical treatment that could affect fertility, or need to use donor gametes, modern medicine offers powerful fertility preservation options.
Egg Freezing (Oocyte Cryopreservation) – Freeze your eggs now for use later. Success rates are highest when treatment is performed before age 35, reflecting better egg quality. Increasingly popular for “social freezing.”
Oncofertility – Urgent fertility preservation before cancer treatment. Options: egg freezing, embryo freezing, and ovarian tissue cryopreservation.
Donor Programs – Donor eggs (success rates primarily reflect donor’s age rather than recipient age), donor sperm, and donor embryos.
So, What Should You Do Now?
If you’ve been trying to conceive without success, here’s a clear path forward:
Step 1: Determine If It’s Time to Seek Help
Under 35? Seek evaluation after 12 months of trying.
35–39? Seek evaluation after 6 months of trying.
40+? Don’t wait—consult a specialist now.
Known risk factors? (irregular periods, PCOS, endometriosis) Seek help sooner.
Step 2: Get Evaluated—Both Partners
For her: Hormonal panel, ultrasound, possibly HSG.
For him: Semen Analysis (Spermiogram) – it’s simple, inexpensive, and can rule out half of the potential causes.
Step 3: Understand Your Diagnosis
Once you know the cause, you can make informed treatment decisions. Most causes have effective solutions.
Step 4: Explore Your Treatment Options
Treatment depends on your specific diagnosis, age, prior treatments, and personal preferences: ovulation induction, surgery, IUI, IVF, or ICSI.
Step 5: Choose the Right Clinic
If you need assisted reproduction, choosing the right clinic is crucial. Consider factors such as reported success rates, available treatments, costs, and clinician experience.
→ Compare fertility clinics worldwide: MedicalNavigator.com/fertility-clinics
Too Long, Didn’t Read
Female infertility is a medical condition affecting 20–35% of cases alone; most causes are identifiable and treatable.
Ovulatory disorders are the most common cause (25–40%) and respond to treatment in up to 80% of cases.
Age is a critical factor: by age 40, the chance of conception per cycle drops to less than 5%.
Letrozole shows a higher live birth rate than clomiphene for PCOS (27.5% vs 19.1%).
IVF success rates reach 40–50% for women under 35, declining with age.
Quitting smoking, maintaining a healthy weight, and seeking timely evaluation are the most impactful first steps.
References
1. World Health Organization. Infertility Fact Sheet. November 2023.
2. Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clinical Biochemistry. 2018;62:2-10.
3. ACOG. Female age-related fertility decline. Committee Opinion No. 589. 2014.
4. Mascarenhas MN, et al. National, regional, and global trends in infertility. PLoS Medicine. 2012;9(12).
5. Gelbaya TA, et al. Definition and epidemiology of unexplained infertility. Obstet Gynecol Survey. 2014;69(2).
6. Agarwal A, et al. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13:37.
7. Adebisi OY, Singh M, Tobler KJ. Female Infertility. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
8. Rotterdam ESHRE/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.
9. Melmed S, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-88.
10. Gordon CM. Functional hypothalamic amenorrhea. N Engl J Med. 2010;363(4):365-71.
11. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31(5):702-55.
12. ASRM. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril. 2021;115(5):1143-1150.
13. Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268-79.
14. Elizur SE, Mostafa J, Berkowitz E, Orvieto R. Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes. Arch Gynecol Obstet. 2025;312(4):1037-1048.
15. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91(4):1215-23.
16. Homan GF, Davies M, Norman R. The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review. Hum Reprod Update. 2007;13(3):209-23.
17. Sharma R, et al. Cigarette smoking and semen quality: a new meta-analysis examining the effect of the 2010 World Health Organization laboratory methods for the examination of human semen. Eur Urol. 2016;70(4):635-645.
18. Practice Committee of ASRM. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2015;103(6):e44-50.
19. Tal R, Seifer DB. Ovarian reserve testing: a user's guide. Am J Obstet Gynecol. 2017;217(2):129-140.
20. Broekmans FJ, de Ziegler D, Howles CM, et al. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94(3):1044-51.
21. Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22.
22. Practice Committee of ASRM. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril. 2013;100(2):341-8.
23. Legro RS, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014;371(2):119-29.
24. Dunselman GA, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400-12.
25. Jacobson TZ, et al. Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev. 2010;(1):CD001398.
26. Bosteels J, et al. The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review. Hum Reprod Update. 2010;16(1):1-11.
27. CDC. 2021 Assisted Reproductive Technology Fertility Clinic and National Summary Report. 2023.
28. Practice Committee of ASRM. Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline. Fertil Steril. 2021;116(1):36-53.
29. Oktay K, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994-2001.
30. Practice Committee of ASRM. Using family members as gamete donors or gestational carriers: an Ethics Committee opinion. Fertil Steril. 2017;107(5):1136-1142.
31. Practice Committee of ASRM. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-11.
32. Zorrilla M, Yatsenko AN. The genetics of infertility: current status of the field. Curr Genet Med Rep. 2013;1(4):247-260.
33. Bachir BG, Jarvi K. Infectious, inflammatory, and immunologic conditions resulting in male infertility. Urol Clin North Am. 2014;41(1):67-81.
34. Bhandari S, Bhave P, Ganguly I, Baxi A, Agarwal P. Reproductive Outcome of Patients with Asherman's Syndrome: A SAIMS Experience. J Reprod Infertil. 2015;16(4):229-235.
35. Kodaman PH, Arici A. Intra-uterine adhesions and fertility outcome: how to optimize success? Curr Opin Obstet Gynecol. 2007;19(3):207-14.
36. Mahalingaiah S, Hart JE, Laden F, et al. Adult air pollution exposure and risk of infertility in the Nurses' Health Study II. Hum Reprod. 2016;31(3):638-47.
37. Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol. 2007;21(2):293-308.
38. Carson SA, Kallen AN. Diagnosis and Management of Infertility: A Review. JAMA. 2021;326(1):65-76.
39. Thoma ME, McLain AC, Louis JF, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99(5):1324-1331.
This guide is for informational purposes only. Always consult qualified healthcare providers for personalized recommendations. For full details, read our Medical Disclaimer.
Date of publication
